Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the long-term safety of an investigational drug versus an approved drug for the relief of pain in patients with rheumatoid arthritis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Diclofenac; Etoricoxib

Criteria

Inclusion Criteria:

• Males and females 50 years or older with rheumatoid arthritis.

Exclusion Criteria:

• History of gastrointestinal malabsorption or inflammatory bowel disease

• History of heart problems such as: congestive heart failure (CHF), heart attack or high blood pressure.